<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39195807</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2306-7381</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Veterinary sciences</Title><ISOAbbreviation>Vet Sci</ISOAbbreviation></Journal><ArticleTitle>Recent Advances in Oral Vaccines for Animals.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">353</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vetsci11080353</ELocationID><Abstract><AbstractText>Compared to traditional injected vaccines, oral vaccines offer significant advantages for the immunization of livestock and wildlife due to their ease of use, high compliance, improved safety, and potential to stimulate mucosal immune responses and induce systemic immunity against pathogens. This review provides an overview of the delivery methods for oral vaccines, and the factors that influence their immunogenicity. We also highlight the global progress and achievements in the development and use of oral vaccines for animals, shedding light on potential future applications in this field.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Kaining</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xinting</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Junhao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Junhui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Minyi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Shuilian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Food Science, Guangdong Pharmaceutical University, Zhongshan 528458, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ju</LastName><ForeName>Chunmei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Animal Vaccine Development of the Ministry of Agriculture and Rural Affairs, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yongwen</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9994-4682</Identifier><AffiliationInfo><Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Animal Vaccine Development of the Ministry of Agriculture and Rural Affairs, South China Agricultural University, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2024A1515010961</GrantID><Agency>Guangdong Basic and Applied Basic Research Foundation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vet Sci</MedlineTA><NlmUniqueID>101680127</NlmUniqueID><ISSNLinking>2306-7381</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">animal health</Keyword><Keyword MajorTopicYN="N">infectious disease</Keyword><Keyword MajorTopicYN="N">mucosal immunity</Keyword><Keyword MajorTopicYN="N">oral vaccines</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>10</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39195807</ArticleId><ArticleId IdType="pmc">PMC11360704</ArticleId><ArticleId IdType="doi">10.3390/vetsci11080353</ArticleId><ArticleId IdType="pii">vetsci11080353</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parida S. Vaccination against Foot-and-Mouth Disease Virus: Strategies and Effectiveness. Expert Rev. Vaccines. 2009;8:347–365. doi: 10.1586/14760584.8.3.347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.8.3.347</ArticleId><ArticleId IdType="pubmed">19249976</ArticleId></ArticleIdList></Reference><Reference><Citation>Moennig V. Introduction to Classical Swine Fever: Virus, Disease and Control Policy. Vet. Microbiol. 2000;73:93–102. doi: 10.1016/S0378-1135(00)00137-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1135(00)00137-1</ArticleId><ArticleId IdType="pubmed">10785320</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkie T.N., Rautenschlein S. Infectious Bursal Disease Virus in Poultry: Current Status and Future Prospects. Vet. Med. 2016;7:9–18. doi: 10.2147/VMRR.S68905.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VMRR.S68905</ArticleId><ArticleId IdType="pmc">PMC6055793</ArticleId><ArticleId IdType="pubmed">30050833</ArticleId></ArticleIdList></Reference><Reference><Citation>Horzinek M.C. Rinderpest: The Second Viral Disease Eradicated. Vet. Microbiol. 2011;149:295–297. doi: 10.1016/j.vetmic.2011.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2011.02.007</ArticleId><ArticleId IdType="pubmed">21435804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwivedy A., Aich P. Importance of Innate Mucosal Immunity and the Promises It Holds. Int. J. Gen. Med. 2011;4:299–311. doi: 10.2147/IJGM.S17525.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S17525</ArticleId><ArticleId IdType="pmc">PMC3085239</ArticleId><ArticleId IdType="pubmed">21556316</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes S.J., Eschmann M., Mantis N.J. Inhibition of Salmonella enterica Serovar Typhimurium Motility and Entry into Epithelial Cells by a Protective Antilipopolysaccharide Monoclonal Immunoglobulin A Antibody. Infect. Immun. 2008;76:4137–4144. doi: 10.1128/IAI.00416-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00416-08</ArticleId><ArticleId IdType="pmc">PMC2519396</ArticleId><ArticleId IdType="pubmed">18625740</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogier E.W., Frantz A.L., Bruno M.E.C., Kaetzel C.S. Secretory IgA Is Concentrated in the Outer Layer of Colonic Mucus along with Gut Bacteria. Pathogens. 2014;3:390–403. doi: 10.3390/pathogens3020390.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens3020390</ArticleId><ArticleId IdType="pmc">PMC4243452</ArticleId><ArticleId IdType="pubmed">25437806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantis N.J., Rol N., Corthésy B. Secretory IgA’s Complex Roles in Immunity and Mucosal Homeostasis in the Gut. Mucosal. Immunol. 2011;4:603–611. doi: 10.1038/mi.2011.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2011.41</ArticleId><ArticleId IdType="pmc">PMC3774538</ArticleId><ArticleId IdType="pubmed">21975936</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannino F., Uriza P.J., Duarte C.M., Pepe M.V., Roset M.S., Briones G. Development of a Salmonella-Based Oral Vaccine to Control Intestinal Colonization of Shiga-Toxin-Producing E. coli (STEC) in Animals. Vaccine. 2022;40:1065–1073. doi: 10.1016/j.vaccine.2022.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.01.032</ArticleId><ArticleId IdType="pubmed">35086742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong K.W.-Y., Xin Y., Lai N.C.-Y., Sung J.C.-C., Wu K.-C., Hamied Y.K., Sze E.T.-P., Lam D.M.-K. Oral Vaccines: A Better Future of Immunization. Vaccines. 2023;11:1232. doi: 10.3390/vaccines11071232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11071232</ArticleId><ArticleId IdType="pmc">PMC10383709</ArticleId><ArticleId IdType="pubmed">37515047</ArticleId></ArticleIdList></Reference><Reference><Citation>Blume S., Geesink I. A Brief History of Polio Vaccines. Science. 2000;288:1593–1594. doi: 10.1126/science.288.5471.1593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.288.5471.1593</ArticleId><ArticleId IdType="pubmed">10858138</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard B.D. A Prototype Live Oral Cholera Vaccine. Nature. 1971;230:97–99. doi: 10.1038/230097a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/230097a0</ArticleId><ArticleId IdType="pubmed">4927022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Liang B., Wang W., Li L., Feng N., Zhao Y., Wang T., Yan F., Yang S., Xia X. Viral Vectored Vaccines: Design, Development, Preventive and Therapeutic Applications in Human Diseases. Signal Transduct. Target. Ther. 2023;8:149. doi: 10.1038/s41392-023-01408-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01408-5</ArticleId><ArticleId IdType="pmc">PMC10081433</ArticleId><ArticleId IdType="pubmed">37029123</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.-X., Hou L.-H., Meng F.-Y., Wu S.-P., Hu Y.-M., Liang Q., Chu K., Zhang Z., Xu J.-J., Tang R., et al. Immunity Duration of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine and a Homologous Prime-Boost Immunisation in Healthy Adults in China: Final Report of a Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial. Lancet Glob. Health. 2017;5:e324–e334. doi: 10.1016/S2214-109X(16)30367-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(16)30367-9</ArticleId><ArticleId IdType="pubmed">28017642</ArticleId></ArticleIdList></Reference><Reference><Citation>Nooraei S., Sarkar Lotfabadi A., Akbarzadehmoallemkolaei M., Rezaei N. Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review. Vaccines. 2023;11:453. doi: 10.3390/vaccines11020453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020453</ArticleId><ArticleId IdType="pmc">PMC9962389</ArticleId><ArticleId IdType="pubmed">36851331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon K.-C., Daniell H. Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells. Mol. Ther. 2016;24:1342–1350. doi: 10.1038/mt.2016.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2016.115</ArticleId><ArticleId IdType="pmc">PMC5023392</ArticleId><ArticleId IdType="pubmed">27378236</ArticleId></ArticleIdList></Reference><Reference><Citation>Sánchez-López E.F., Corigliano M.G., Oliferuk S., Ramos-Duarte V.A., Rivera M., Mendoza-Morales L.F., Angel S.O., Sander V.A., Clemente M. Oral Immunization With a Plant HSP90-SAG1 Fusion Protein Produced in Tobacco Elicits Strong Immune Responses and Reduces Cyst Number and Clinical Signs of Toxoplasmosis in Mice. Front. Plant Sci. 2021;12:726910. doi: 10.3389/fpls.2021.726910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2021.726910</ArticleId><ArticleId IdType="pmc">PMC8525317</ArticleId><ArticleId IdType="pubmed">34675949</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahid N., Daniell H. Plant-Based Oral Vaccines against Zoonotic and Non-Zoonotic Diseases. Plant Biotechnol. J. 2016;14:2079–2099. doi: 10.1111/pbi.12604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pbi.12604</ArticleId><ArticleId IdType="pmc">PMC5095797</ArticleId><ArticleId IdType="pubmed">27442628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartenstein V., Martinez P. Structure, Development and Evolution of the Digestive System. Cell Tissue Res. 2019;377:289–292. doi: 10.1007/s00441-019-03102-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-019-03102-x</ArticleId><ArticleId IdType="pmc">PMC6820690</ArticleId><ArticleId IdType="pubmed">31478136</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavot V., Rochereau N., Genin C., Verrier B., Paul S. New Insights in Mucosal Vaccine Development. Vaccine. 2012;30:142–154. doi: 10.1016/j.vaccine.2011.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.11.003</ArticleId><ArticleId IdType="pubmed">22085556</ArticleId></ArticleIdList></Reference><Reference><Citation>Vela Ramirez J.E., Sharpe L.A., Peppas N.A. Current State and Challenges in Developing Oral Vaccines. Adv. Drug Deliv. Rev. 2017;114:116–131. doi: 10.1016/j.addr.2017.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2017.04.008</ArticleId><ArticleId IdType="pmc">PMC6132247</ArticleId><ArticleId IdType="pubmed">28438674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Li M., Du G., Chen X., Sun X. Advancedoral Vaccine Delivery Strategies for Improving the Immunity. Adv. Drug Deliv. Rev. 2021;177:113928. doi: 10.1016/j.addr.2021.113928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2021.113928</ArticleId><ArticleId IdType="pubmed">34411689</ArticleId></ArticleIdList></Reference><Reference><Citation>Davitt C.J.H., Lavelle E.C. Delivery Strategies to Enhance Oral Vaccination against Enteric Infections. Adv. Drug Deliv. Rev. 2015;91:52–69. doi: 10.1016/j.addr.2015.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2015.03.007</ArticleId><ArticleId IdType="pubmed">25817337</ArticleId></ArticleIdList></Reference><Reference><Citation>Misumi S., Masuyama M., Takamune N., Nakayama D., Mitsumata R., Matsumoto H., Urata N., Takahashi Y., Muneoka A., Sukamoto T., et al. Targeted Delivery of Immunogen to Primate m Cells with Tetragalloyl Lysine Dendrimer. J. Immunol. 2009;182:6061–6070. doi: 10.4049/jimmunol.0802928.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0802928</ArticleId><ArticleId IdType="pubmed">19414757</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.-S., Piao D.-C., Jiang T., Bok J.-D., Cho C.-S., Lee Y.-S., Kang S.-K., Choi Y.-J. Recombinant Interleukin 6 with M Cell-Targeting Moiety Produced in Lactococcus Lactis IL1403 as a Potent Mucosal Adjuvant for Peroral Immunization. Vaccine. 2015;33:1959–1967. doi: 10.1016/j.vaccine.2015.02.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.02.061</ArticleId><ArticleId IdType="pubmed">25738814</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo M.-K., Kang S.-K., Choi J.-H., Park I.-K., Na H.-S., Lee H.-C., Kim E.-B., Lee N.-K., Nah J.-W., Choi Y.-J., et al. Targeted Delivery of Chitosan Nanoparticles to Peyer’s Patch Using M Cell-Homing Peptide Selected by Phage Display Technique. Biomaterials. 2010;31:7738–7747. doi: 10.1016/j.biomaterials.2010.06.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2010.06.059</ArticleId><ArticleId IdType="pubmed">20656343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Zhang Z., Li X., Li J., Lv J., Ma Z., Pan L. Immune Responses to Orally Administered Recombinant Lactococcus Lactis Expressing Multi-Epitope Proteins Targeting M Cells of Foot-and-Mouth Disease Virus. Viruses. 2021;13:2036. doi: 10.3390/v13102036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13102036</ArticleId><ArticleId IdType="pmc">PMC8537116</ArticleId><ArticleId IdType="pubmed">34696469</ArticleId></ArticleIdList></Reference><Reference><Citation>Agirman G., Yu K.B., Hsiao E.Y. Signaling Inflammation across the Gut-Brain Axis. Science. 2021;374:1087–1092. doi: 10.1126/science.abi6087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abi6087</ArticleId><ArticleId IdType="pubmed">34822299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Curtis N. The Influence of the Intestinal Microbiome on Vaccine Responses. Vaccine. 2018;36:4433–4439. doi: 10.1016/j.vaccine.2018.04.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.04.066</ArticleId><ArticleId IdType="pubmed">29909134</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Chen X., Qiu S., Hu Y., Jiang C., Wang D., Fan Q., Zhang C., Huang Y., Yu Y., et al. Effects of Epimedium Polysaccharide-Propolis Flavone Oral Liquid on Mucosal Immunity in Chickens. Int. J. Biol. Macromol. 2014;64:6–10. doi: 10.1016/j.ijbiomac.2013.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2013.11.015</ArticleId><ArticleId IdType="pubmed">24296407</ArticleId></ArticleIdList></Reference><Reference><Citation>Fingerut E., Gutter B., Goldway M., Eliahoo D., Pitcovski J. B Subunit of E. coli Enterotoxin as Adjuvant and Carrier in Oral and Skin Vaccination. Vet. Immunol. Immunopathol. 2006;112:253–263. doi: 10.1016/j.vetimm.2006.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2006.03.005</ArticleId><ArticleId IdType="pubmed">16701905</ArticleId></ArticleIdList></Reference><Reference><Citation>Means T.K., Hayashi F., Smith K.D., Aderem A., Luster A.D. The Toll-like Receptor 5 Stimulus Bacterial Flagellin Induces Maturation and Chemokine Production in Human Dendritic Cells. J. Immunol. 2003;170:5165–5175. doi: 10.4049/jimmunol.170.10.5165.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.10.5165</ArticleId><ArticleId IdType="pubmed">12734364</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Zhang G., Ren G., Gnanadurai C.W., Li Z., Chai Q., Yang Y., Leyson C.M., Wu W., Cui M., et al. Recombinant Rabies Viruses Expressing GM-CSF or Flagellin Are Effective Vaccines for Both Intramuscular and Oral Immunizations. PLoS ONE. 2013;8:e63384. doi: 10.1371/journal.pone.0063384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063384</ArticleId><ArticleId IdType="pmc">PMC3658976</ArticleId><ArticleId IdType="pubmed">23700422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T., Yamamoto S., Kataoka T., Tokunaga T. Lipofection of Synthetic Oligodeoxyribonucleotide Having a Palindromic Sequence of AACGTT to Murine Splenocytes Enhances Interferon Production and Natural Killer Activity. Microbiol. Immunol. 1994;38:831–836. doi: 10.1111/j.1348-0421.1994.tb01867.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.1994.tb01867.x</ArticleId><ArticleId IdType="pubmed">7532782</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien E., Nilsen N.J., Espevik T., Golenbock D.T. TLR9 Signals after Translocating from the ER to CpG DNA in the Lysosome. Nat. Immunol. 2004;5:190–198. doi: 10.1038/ni1028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1028</ArticleId><ArticleId IdType="pubmed">14716310</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha-Abdelaziz K., Hodgins D.C., Alkie T.N., Quinteiro-Filho W., Yitbarek A., Astill J., Sharif S. Oral Administration of PLGA-Encapsulated CpG ODN and Campylobacter jejuni Lysate Reduces Cecal Colonization by Campylobacter jejuni in Chickens. Vaccine. 2018;36:388–394. doi: 10.1016/j.vaccine.2017.11.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.11.073</ArticleId><ArticleId IdType="pubmed">29223488</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell J.E., Kurtz J.R., Bauer D.L., Prior J.T., Gellings P.S., Morici L.A., McLachlan J.B. An Outer Membrane Vesicle-Adjuvanted Oral Vaccine Protects Against Lethal, Oral Salmonella Infection. Pathogens. 2021;10:616. doi: 10.3390/pathogens10050616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10050616</ArticleId><ArticleId IdType="pmc">PMC8157261</ArticleId><ArticleId IdType="pubmed">34069796</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Teng Z., Lu Y., Luo X., Mu S., Ru J., Zhao X., Guo H., Ran X., Wen X., et al. Enhanced Immunogenicity of Foot and Mouth Disease DNA Vaccine Delivered by PLGA Nanoparticles Combined with Cytokine Adjuvants. Res. Vet. Sci. 2021;136:89–96. doi: 10.1016/j.rvsc.2021.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rvsc.2021.02.010</ArticleId><ArticleId IdType="pubmed">33592449</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Wang B., Wang M. GM-CSF and IL-2 as Adjuvant Enhance the Immune Effect of Protein Vaccine against Foot-and-Mouth Disease. Virol. J. 2011;8:7. doi: 10.1186/1743-422X-8-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-7</ArticleId><ArticleId IdType="pmc">PMC3024958</ArticleId><ArticleId IdType="pubmed">21214955</ArticleId></ArticleIdList></Reference><Reference><Citation>Caligiuri M.A., Murray C., Robertson M.J., Wang E., Cochran K., Cameron C., Schow P., Ross M.E., Klumpp T.R., Soiffer R.J. Selective Modulation of Human Natural Killer Cells in Vivo after Prolonged Infusion of Low Dose Recombinant Interleukin 2. J. Clin. Investig. 1993;91:123–132. doi: 10.1172/JCI116161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI116161</ArticleId><ArticleId IdType="pmc">PMC330005</ArticleId><ArticleId IdType="pubmed">7678599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonwitt J., Bonaparte S., Blanton J., Gibson A.D., Hoque M., Kennedy E., Islam K., Siddiqi U.R., Wallace R.M., Azam S. Oral Bait Preferences and Feasibility of Oral Rabies Vaccination in Bangladeshi Dogs. Vaccine. 2020;38:5021–5026. doi: 10.1016/j.vaccine.2020.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.05.047</ArticleId><ArticleId IdType="pubmed">32513512</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowtage S., Williams G.A., Henderson R., Aylett P., MacMorran D., Palmer S., Robertson A., Lesellier S., Carter S.P., Chambers M.A. Testing of a Palatable Bait and Compatible Vaccine Carrier for the Oral Vaccination of European Badgers (Meles meles) against Tuberculosis. Vaccine. 2017;35:987–992. doi: 10.1016/j.vaccine.2016.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.12.004</ArticleId><ArticleId IdType="pubmed">28077246</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson S.R., Crider N.J., Weyer G.A., Tosh R.D., VerCauteren K.C. Bait Development For Oral Delivery Of Pharmaceuticals To Raccoons (Procyon Lotor) And Striped Skunks (Mephitis Mephitis) J. Wildl. Dis. 2016;52:893–901. doi: 10.7589/2015-12-322.</Citation><ArticleIdList><ArticleId IdType="doi">10.7589/2015-12-322</ArticleId><ArticleId IdType="pubmed">27505038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage M., Fourel I., Lahoreau J., Siat V., Berny P., Rossi S. Iophenoxic Acid Derivatives as Markers of Oral Baits to Wildlife. New Tools for Their Detection in Tissues of a Game Species and Safety Considerations for Human Exposure. Environ. Sci. Pollut. Res. Int. 2013;20:2893–2904. doi: 10.1007/s11356-012-1172-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-012-1172-x</ArticleId><ArticleId IdType="pubmed">23001758</ArticleId></ArticleIdList></Reference><Reference><Citation>Robardet E., Rieder J., Barrat J., Cliquet F. Reconsidering Oral Rabies Vaccine Bait Uptake Evaluation at Population Level: A Simple, Noninvasive, and Ethical Method by Fecal Survey Using a Physical Biomarker. J. Wildl. Dis. 2019;55:200–205. doi: 10.7589/2018-02-045.</Citation><ArticleIdList><ArticleId IdType="doi">10.7589/2018-02-045</ArticleId><ArticleId IdType="pubmed">30016214</ArticleId></ArticleIdList></Reference><Reference><Citation>Langguth A., Leelahapongsathon K., Wannapong N., Kasemsuwan S., Ortmann S., Vos A., Böer M. Comparative Study of Optical Markers to Assess Bait System Efficiency Concerning Vaccine Release in the Oral Cavity of Dogs. Viruses. 2021;13:1382. doi: 10.3390/v13071382.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071382</ArticleId><ArticleId IdType="pmc">PMC8310038</ArticleId><ArticleId IdType="pubmed">34372588</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter S.P., Robertson A., Palphramand K.L., Chambers M.A., McDonald R.A., Delahay R.J. Bait Uptake by Wild Badgers and Its Implications for Oral Vaccination against Tuberculosis. PLoS ONE. 2018;13:e0206136. doi: 10.1371/journal.pone.0206136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206136</ArticleId><ArticleId IdType="pmc">PMC6226152</ArticleId><ArticleId IdType="pubmed">30412584</ArticleId></ArticleIdList></Reference><Reference><Citation>Tizard I.R. Chapter 8—The Administration of Vaccines. In: Tizard I.R., editor. Vaccines for Veterinarians. Elsevier; Amsterdam, The Netherlands: 2021. pp. 87–104.e1.</Citation></Reference><Reference><Citation>Vos A., Freuling C.M., Hundt B., Kaiser C., Nemitz S., Neubert A., Nolden T., Teifke J.P., Te Kamp V., Ulrich R., et al. Oral Vaccination of Wildlife against Rabies: Differences among Host Species in Vaccine Uptake Efficiency. Vaccine. 2017;35:3938–3944. doi: 10.1016/j.vaccine.2017.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.06.022</ArticleId><ArticleId IdType="pubmed">28641888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Wang L., Zhou S., Wang Z., Ruan J., Tang L., Jia Z., Cui M., Zhao L., Fu Z.F. Recombinant Rabies Virus Expressing Dog GM-CSF Is an Efficacious Oral Rabies Vaccine for Dogs. Oncotarget. 2015;6:38504–38516. doi: 10.18632/oncotarget.5904.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.5904</ArticleId><ArticleId IdType="pmc">PMC4770717</ArticleId><ArticleId IdType="pubmed">26436700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Kamada N., Moon J.J. Oral Nanomedicine for Modulating Immunity, Intestinal Barrier Functions, and Gut Microbiome. Adv. Drug Deliv. Rev. 2021;179:114021. doi: 10.1016/j.addr.2021.114021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2021.114021</ArticleId><ArticleId IdType="pmc">PMC8665886</ArticleId><ArticleId IdType="pubmed">34710529</ArticleId></ArticleIdList></Reference><Reference><Citation>Danhier F., Ansorena E., Silva J.M., Coco R., Le Breton A., Préat V. PLGA-Based Nanoparticles: An Overview of Biomedical Applications. J. Control Release. 2012;161:505–522. doi: 10.1016/j.jconrel.2012.01.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2012.01.043</ArticleId><ArticleId IdType="pubmed">22353619</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo-Villanueva K., Akerele G., Al-Hakeem W., Adams D., Gourapura R., Selvaraj R. Immunization of Broiler Chickens With a Killed Chitosan Nanoparticle Salmonella Vaccine Decreases Salmonella Enterica Serovar Enteritidis Load. Front. Physiol. 2022;13:920777. doi: 10.3389/fphys.2022.920777.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.920777</ArticleId><ArticleId IdType="pmc">PMC9340066</ArticleId><ArticleId IdType="pubmed">35923229</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimarães D., Cavaco-Paulo A., Nogueira E. Design of Liposomes as Drug Delivery System for Therapeutic Applications. Int. J. Pharm. 2021;601:120571. doi: 10.1016/j.ijpharm.2021.120571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2021.120571</ArticleId><ArticleId IdType="pubmed">33812967</ArticleId></ArticleIdList></Reference><Reference><Citation>Defrise-Quertain F., Chatelain P., Ruysschaert J.M., Delmelle M. Spin Label Partitioning in Lipid Vesicles. A Model Study for Drug Encapsulation. Biochim. Biophys. Acta. 1980;628:57–68. doi: 10.1016/0304-4165(80)90351-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-4165(80)90351-7</ArticleId><ArticleId IdType="pubmed">6243999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkhu J.S., McNeil S.E., Anderson D.E., Perrie Y. Characterization and Optimization of Bilosomes for Oral Vaccine Delivery. J. Drug Target. 2013;21:291–299. doi: 10.3109/1061186X.2012.747528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1061186X.2012.747528</ArticleId><ArticleId IdType="pubmed">30952177</ArticleId></ArticleIdList></Reference><Reference><Citation>Conacher M., Alexander J., Brewer J.M. Oral Immunisation with Peptide and Protein Antigens by Formulation in Lipid Vesicles Incorporating Bile Salts (Bilosomes) Vaccine. 2001;19:2965–2974. doi: 10.1016/S0264-410X(00)00537-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(00)00537-5</ArticleId><ArticleId IdType="pubmed">11282208</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S., Harde H., Indulkar A., Agrawal A.K. Improved Stability and Immunological Potential of Tetanus Toxoid Containing Surface Engineered Bilosomes Following Oral Administration. Nanomedicine. 2014;10:431–440. doi: 10.1016/j.nano.2013.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nano.2013.08.012</ArticleId><ArticleId IdType="pubmed">24036099</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Liu D., Booth G., Gao W., Lu Y. Virus-Like Particle Engineering: From Rational Design to Versatile Applications. Biotechnol. J. 2018;13:e1700324. doi: 10.1002/biot.201700324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biot.201700324</ArticleId><ArticleId IdType="pubmed">29453861</ArticleId></ArticleIdList></Reference><Reference><Citation>Serradell M.C., Rupil L.L., Martino R.A., Prucca C.G., Carranza P.G., Saura A., Fernández E.A., Gargantini P.R., Tenaglia A.H., Petiti J.P., et al. Efficient Oral Vaccination by Bioengineering Virus-like Particles with Protozoan Surface Proteins. Nat. Commun. 2019;10:361. doi: 10.1038/s41467-018-08265-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-08265-9</ArticleId><ArticleId IdType="pmc">PMC6341118</ArticleId><ArticleId IdType="pubmed">30664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Jiang H., Yang R., Zhang S., Zhao W., Hu J., Jiang Y., Yang W., Huang H., Shi C., et al. Construction and Evaluation of Recombinant Lactobacillus plantarum NC8 Delivering One Single or Two Copies of G Protein Fused with a DC-Targeting Peptide (DCpep) as Novel Oral Rabies Vaccine. Vet. Microbiol. 2020;251:108906. doi: 10.1016/j.vetmic.2020.108906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2020.108906</ArticleId><ArticleId IdType="pubmed">33160196</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Wang X., Li Y., Li F., Zhao H., Shao Y., Zhang L., Ding G., Li J., Jiang Y., et al. Evaluation of the Immunogenicity in Mice Orally Immunized with Recombinant Lactobacillus Casei Expressing Porcine Epidemic Diarrhea Virus S1 Protein. Viruses. 2022;14:890. doi: 10.3390/v14050890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14050890</ArticleId><ArticleId IdType="pmc">PMC9145290</ArticleId><ArticleId IdType="pubmed">35632632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.N., Wang L., Zheng D.Z., Chen S., Shi W., Qiao X.Y., Jiang Y.P., Tang L.J., Xu Y.G., Li Y.J. Oral Immunization with a Lactobacillus Casei-Based Anti-Porcine Epidemic Diarrhoea Virus (PEDV) Vaccine Expressing Microfold Cell-Targeting Peptide Co1 Fused with the COE Antigen of PEDV. J. Appl. Microbiol. 2018;124:368–378. doi: 10.1111/jam.13652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jam.13652</ArticleId><ArticleId IdType="pubmed">29178509</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam M.A., Rydström A., Sundquist M., Wick M.J. Early Cellular Responses to Salmonella Infection: Dendritic Cells, Monocytes, and More. Immunol. Rev. 2008;225:140–162. doi: 10.1111/j.1600-065X.2008.00679.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00679.x</ArticleId><ArticleId IdType="pubmed">18837781</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtiss R., Nakayama K., Kelly S.M. Recombinant Avirulent Salmonella Vaccine Strains with Stable Maintenance and High Level Expression of Cloned Genes in Vivo. Immunol. Investig. 1989;18:583–596. doi: 10.3109/08820138909112265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08820138909112265</ArticleId><ArticleId IdType="pubmed">2659521</ArticleId></ArticleIdList></Reference><Reference><Citation>Senevirathne A., Hewawaduge C., Park S., Jawalagatti V., Kim C., Seo B.-J., Lee E., Lee J.H. Single Oral Immunization of an Attenuated Salmonella Gallinarium Formulation Consisting of Equal Quantities of Strains Secreting H9N2 Hemagglutinin-HA1, HA2, and M2eCD154 Induces Significant Protection against H9N2 and Partial Protection against Salmonella Gallinarium Challenge in Chickens. Vet. Immunol. Immunopathol. 2021;240:110318. doi: 10.1016/j.vetimm.2021.110318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2021.110318</ArticleId><ArticleId IdType="pubmed">34479105</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover A., McLean J.L., Troudt J.M., Foster C., Izzo L., Creissen E., MacDonald E., Troy A., Izzo A.A. Heat Killed Saccharomyces Cerevisiae as an Adjuvant for the Induction of Vaccine-Mediated Immunity against Infection with Mycobacterium Tuberculosis. Vaccine. 2016;34:2798–2805. doi: 10.1016/j.vaccine.2016.04.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.04.052</ArticleId><ArticleId IdType="pubmed">27131285</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascio V., Gittings D., Merloni K., Hurton M., Laprade D., Austriaco N. S-Adenosyl-L-Methionine Protects the Probiotic Yeast, Saccharomyces Boulardii, from Acid-Induced Cell Death. BMC Microbiol. 2013;13:35. doi: 10.1186/1471-2180-13-35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-13-35</ArticleId><ArticleId IdType="pmc">PMC3639806</ArticleId><ArticleId IdType="pubmed">23402325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H., Jin S., Karlsson E., Schultz-Cherry S., Ye K. Yeast Surface-Displayed H5N1 Avian Influenza Vaccines. J. Immunol. Res. 2016;2016:4131324. doi: 10.1155/2016/4131324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4131324</ArticleId><ArticleId IdType="pmc">PMC5204078</ArticleId><ArticleId IdType="pubmed">28078309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova E. Yeasts in Nanotechnology-Enabled Oral Vaccine and Gene Delivery. Bioengineered. 2021;12:8325–8335. doi: 10.1080/21655979.2021.1985816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2021.1985816</ArticleId><ArticleId IdType="pmc">PMC8806958</ArticleId><ArticleId IdType="pubmed">34592900</ArticleId></ArticleIdList></Reference><Reference><Citation>Maki J., Guiot A.-L., Aubert M., Brochier B., Cliquet F., Hanlon C.A., King R., Oertli E.H., Rupprecht C.E., Schumacher C., et al. Oral Vaccination of Wildlife Using a Vaccinia-Rabies-Glycoprotein Recombinant Virus Vaccine (RABORAL V-RG®): A Global Review. Vet. Res. 2017;48:57. doi: 10.1186/s13567-017-0459-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13567-017-0459-9</ArticleId><ArticleId IdType="pmc">PMC5610451</ArticleId><ArticleId IdType="pubmed">28938920</ArticleId></ArticleIdList></Reference><Reference><Citation>Roess A.A., Rea N., Lederman E., Dato V., Chipman R., Slate D., Reynolds M.G., Damon I.K., Rupprecht C.E. National Surveillance for Human and Pet Contact with Oral Rabies Vaccine Baits, 2001-2009. J. Am. Vet. Med. Assoc. 2012;240:163–168. doi: 10.2460/javma.240.2.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.2460/javma.240.2.163</ArticleId><ArticleId IdType="pubmed">22217024</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert A., Johnson S., Walker N., Wickham C., Beath A., VerCauteren K. Efficacy of Ontario Rabies Vaccine Baits (ONRAB) against Rabies Infection in Raccoons. Vaccine. 2018;36:4919–4926. doi: 10.1016/j.vaccine.2018.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.06.052</ArticleId><ArticleId IdType="pubmed">30037482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.-C., Guan X.-H., Li Y.-H., Huang J.-Y., Jiang T., Hou L.-H., Li J.-X., Yang B.-F., Wang L., Wang W.-J., et al. Immunogenicity and Safety of a Recombinant Adenovirus Type-5-Vectored COVID-19 Vaccine in Healthy Adults Aged 18 Years or Older: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial. Lancet. 2020;396:479–488. doi: 10.1016/S0140-6736(20)31605-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31605-6</ArticleId><ArticleId IdType="pmc">PMC7836858</ArticleId><ArticleId IdType="pubmed">32702299</ArticleId></ArticleIdList></Reference><Reference><Citation>Voysey M., Clemens S.A.C., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., Angus B., Baillie V.L., Barnabas S.L., Bhorat Q.E., et al. Safety and Efficacy of the ChAdOx1 nCoV-19 Vaccine (AZD1222) against SARS-CoV-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111. doi: 10.1016/S0140-6736(20)32661-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32661-1</ArticleId><ArticleId IdType="pmc">PMC7723445</ArticleId><ArticleId IdType="pubmed">33306989</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosatte R.C., Donovan D., Davies J.C., Allan M., Bachmann P., Stevenson B., Sobey K., Brown L., Silver A., Bennett K., et al. Aerial Distribution of ONRAB Baits as a Tactic to Control Rabies in Raccoons and Striped Skunks in Ontario, Canada. J. Wildl. Dis. 2009;45:363–374. doi: 10.7589/0090-3558-45.2.363.</Citation><ArticleIdList><ArticleId IdType="doi">10.7589/0090-3558-45.2.363</ArticleId><ArticleId IdType="pubmed">19395746</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown L.J., Rosatte R.C., Fehlner-Gardiner C., Taylor J.S., Davies J.C., Donovan D. Immune Response and Protection in Raccoons (Procyon lotor) Following Consumption of Baits Containing ONRAB®, a Human Adenovirus Rabies Glycoprotein Recombinant Vaccine. J. Wildl. Dis. 2012;48:1010–1020. doi: 10.7589/2012-01-023.</Citation><ArticleIdList><ArticleId IdType="doi">10.7589/2012-01-023</ArticleId><ArticleId IdType="pubmed">23060502</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobey K.G., Jamieson S.E., Walpole A.A., Rosatte R.C., Donovan D., Fehlner-Gardiner C., Nadin-Davis S.A., Davies J.C., Kyle C.J. ONRAB® Oral Rabies Vaccine Is Shed from, but Does Not Persist in, Captive Mammals. Vaccine. 2019;37:4310–4317. doi: 10.1016/j.vaccine.2019.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.06.046</ArticleId><ArticleId IdType="pubmed">31248686</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles M.K., Nadin-Davis S.A., Sheen M., Rosatte R., Mueller R., Beresford A. Safety Studies on an Adenovirus Recombinant Vaccine for Rabies (AdRG1.3-ONRAB) in Target and Non-Target Species. Vaccine. 2009;27:6619–6626. doi: 10.1016/j.vaccine.2009.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.08.005</ArticleId><ArticleId IdType="pubmed">19698811</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown L.J., Rosatte R.C., Fehlner-Gardiner C., Ellison J.A., Jackson F.R., Bachmann P., Taylor J.S., Franka R., Donovan D. Oral Vaccination and Protection of Striped Skunks (Mephitis mephitis) against Rabies Using ONRAB®. Vaccine. 2014;32:3675–3679. doi: 10.1016/j.vaccine.2014.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.04.029</ArticleId><ArticleId IdType="pubmed">24814554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Liu Y., Zhang S., Fang L., Zhang F., Hu R. Experimental Oral Immunization of Ferret Badgers (Melogale Moschata) with a Recombinant Canine Adenovirus Vaccine CAV-2-E3Δ-RGP and an Attenuated Rabies Virus SRV9. J. Wildl. Dis. 2014;50:374–377. doi: 10.7589/2013-01-020.</Citation><ArticleIdList><ArticleId IdType="doi">10.7589/2013-01-020</ArticleId><ArticleId IdType="pubmed">24506428</ArticleId></ArticleIdList></Reference><Reference><Citation>Shojaei Jeshvaghani F., Amani J., Kazemi R., Karimi Rahjerdi A., Jafari M., Abbasi S., Salmanian A.H. Oral Immunization with a Plant-Derived Chimeric Protein in Mice: Toward the Development of a Multipotent Edible Vaccine against E. coli O157: H7 and ETEC. Immunobiology. 2019;224:262–269. doi: 10.1016/j.imbio.2018.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2018.12.001</ArticleId><ArticleId IdType="pubmed">30579628</ArticleId></ArticleIdList></Reference><Reference><Citation>Maj M., Fake G.M., Walker J.H., Saltzman R., Howard J.A. Oral Administration of Coronavirus Spike Protein Provides Protection to Newborn Pigs When Challenged with PEDV. Vaccines. 2021;9:1416. doi: 10.3390/vaccines9121416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9121416</ArticleId><ArticleId IdType="pmc">PMC8706244</ArticleId><ArticleId IdType="pubmed">34960163</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos A., Freuling C., Ortmann S., Kretzschmar A., Mayer D., Schliephake A., Müller T. An Assessment of Shedding with the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Target and Non-Target Species. Vaccine. 2018;36:811–817. doi: 10.1016/j.vaccine.2017.12.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.12.076</ArticleId><ArticleId IdType="pubmed">29325820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortmann S., Kretzschmar A., Kaiser C., Lindner T., Freuling C., Kaiser C., Schuster P., Mueller T., Vos A. In Vivo Safety Studies With SPBN GASGAS in the Frame of Oral Vaccination of Foxes and Raccoon Dogs Against Rabies. Front. Vet. Sci. 2018;5:91. doi: 10.3389/fvets.2018.00091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2018.00091</ArticleId><ArticleId IdType="pmc">PMC5968751</ArticleId><ArticleId IdType="pubmed">29868616</ArticleId></ArticleIdList></Reference><Reference><Citation>Faber M., Dietzschold B., Li J. Immunogenicity and Safety of Recombinant Rabies Viruses Used for Oral Vaccination of Stray Dogs and Wildlife. Zoonoses Public Health. 2009;56:262–269. doi: 10.1111/j.1863-2378.2008.01215.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1863-2378.2008.01215.x</ArticleId><ArticleId IdType="pubmed">19486317</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D.-K., Kim H.-H., Choi S.-S., Kim J.-T., Jeong W.-H., Song J.-Y. Oral Immunization of Mice with Recombinant Rabies Vaccine Strain (ERAG3G) Induces Complete Protection. Clin. Exp. Vaccine Res. 2015;4:107–113. doi: 10.7774/cevr.2015.4.1.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2015.4.1.107</ArticleId><ArticleId IdType="pmc">PMC4313102</ArticleId><ArticleId IdType="pubmed">25648184</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai L., Feng N., Wang X., Ge J., Wen Z., Chen W., Qin L., Xia X., Bu Z. Genetically Modified Rabies Virus ERA Strain Is Safe and Induces Long-Lasting Protective Immune Response in Dogs after Oral Vaccination. Antiviral. Res. 2015;121:9–15. doi: 10.1016/j.antiviral.2015.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.06.011</ArticleId><ArticleId IdType="pubmed">26093157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sillero-Zubiri C., Marino J., Gordon C.H., Bedin E., Hussein A., Regassa F., Banyard A., Fooks A.R. Feasibility and Efficacy of Oral Rabies Vaccine SAG2 in Endangered Ethiopian Wolves. Vaccine. 2016;34:4792–4798. doi: 10.1016/j.vaccine.2016.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.08.021</ArticleId><ArticleId IdType="pubmed">27543453</ArticleId></ArticleIdList></Reference><Reference><Citation>Freuling C.M., Kamp V.T., Klein A., Günther M., Zaeck L., Potratz M., Eggerbauer E., Bobe K., Kaiser C., Kretzschmar A., et al. Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes. Viruses. 2019;11:790. doi: 10.3390/v11090790.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11090790</ArticleId><ArticleId IdType="pmc">PMC6784248</ArticleId><ArticleId IdType="pubmed">31461981</ArticleId></ArticleIdList></Reference><Reference><Citation>Freuling C.M., Eggerbauer E., Finke S., Kaiser C., Kaiser C., Kretzschmar A., Nolden T., Ortmann S., Schröder C., Teifke J.P., et al. Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes and Raccoon Dogs. Vaccine. 2019;37:4750–4757. doi: 10.1016/j.vaccine.2017.09.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.09.093</ArticleId><ArticleId IdType="pubmed">29042202</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T.G., Millien M., Vos A., Fracciterne F.A., Crowdis K., Chirodea C., Medley A., Chipman R., Qin Y., Blanton J., et al. Evaluation of Immune Responses in Dogs to Oral Rabies Vaccine under Field Conditions. Vaccine. 2019;37:4743–4749. doi: 10.1016/j.vaccine.2017.09.096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.09.096</ArticleId><ArticleId IdType="pmc">PMC5904025</ArticleId><ArticleId IdType="pubmed">29054727</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos A., Nokireki T., Isomursu M., Gadd T., Kovacs F. Oral Vaccination of Foxes and Raccoon Dogs against Rabies with the 3rd Generation Oral Rabies Virus Vaccine, SPBN GASGAS, in Finland. Acta Vet. Scand. 2021;63:40. doi: 10.1186/s13028-021-00605-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13028-021-00605-y</ArticleId><ArticleId IdType="pmc">PMC8513320</ArticleId><ArticleId IdType="pubmed">34645487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Zhang Y., Chen Y., Zhang J., Pei J., Cui M., Fu Z.F., Zhao L., Zhou M. A Novel Oral Rabies Vaccine Enhances the Immunogenicity through Increasing Dendritic Cells Activation and Germinal Center Formation by Expressing U-OMP19 in a Mouse Model. Emerg. Microbes. Infect. 2021;10:913–928. doi: 10.1080/22221751.2021.1923341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1923341</ArticleId><ArticleId IdType="pmc">PMC8143638</ArticleId><ArticleId IdType="pubmed">33905300</ArticleId></ArticleIdList></Reference><Reference><Citation>Zienius D., Mickutė J., Pautienius A., Grigas J., Stankevičius A., Pridotkas G., Jacevičius E., Kemeraitė J., Jacevičienė I. Analysis of Seroprevalence in Target Wildlife during the Oral Rabies Vaccination Programme in Lithuania. Acta Vet. Scand. 2021;63:12. doi: 10.1186/s13028-021-00577-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13028-021-00577-z</ArticleId><ArticleId IdType="pmc">PMC7981835</ArticleId><ArticleId IdType="pubmed">33743780</ArticleId></ArticleIdList></Reference><Reference><Citation>Megawati Saputra I.L., Suwarno S., Husein W.F., Suseno P.P., Prayoga I.M.A., Vos A., Arthawan I.M., Schoonman L., Weaver J., Zainuddin N. Immunogenicity of Oral Rabies Vaccine Strain SPBN GASGAS in Local Dogs in Bali, Indonesia. Viruses. 2023;15:1405. doi: 10.3390/v15061405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15061405</ArticleId><ArticleId IdType="pmc">PMC10303320</ArticleId><ArticleId IdType="pubmed">37376704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Liu J., Wu X., Yu L., Chen H., Guo H., Zhang M., Li H., Liu X., Sun S., et al. Oral Immunisation of Mice with a Recombinant Rabies Virus Vaccine Incorporating the Heat-Labile Enterotoxin B Subunit of E. coli in an Attenuated Salmonella Strain. Res. Vet. Sci. 2012;93:675–681. doi: 10.1016/j.rvsc.2011.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rvsc.2011.09.015</ArticleId><ArticleId IdType="pubmed">22019192</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown L.J., Rosatte R.C., Fehlner-Gardiner C., Bachmann P., Ellison J.A., Jackson F.R., Taylor J.S., Davies C., Donovan D. Oral Vaccination and Protection of Red Foxes (Vulpes vulpes) against Rabies Using ONRAB, an Adenovirus-Rabies Recombinant Vaccine. Vaccine. 2014;32:984–989. doi: 10.1016/j.vaccine.2013.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.12.015</ArticleId><ArticleId IdType="pubmed">24374501</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentsen A.R., Leinbach I.L., Rivera-Rodriguez M.J., Gilbert A.T. Oral Rabies Vaccination of Small Indian Mongooses (Urva Auropunctata) with ONRAB via Ultralite Baits. Viruses. 2021;13:734. doi: 10.3390/v13050734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050734</ArticleId><ArticleId IdType="pmc">PMC8144982</ArticleId><ArticleId IdType="pubmed">33922562</ArticleId></ArticleIdList></Reference><Reference><Citation>Murr M., Freuling C., Pérez-Bravo D., Grund C., Mettenleiter T.C., Römer-Oberdörfer A., Müller T., Finke S. Immune Response after Oral Immunization of Goats and Foxes with an NDV Vectored Rabies Vaccine Candidate. PLoS Negl. Trop Dis. 2024;18:e0011639. doi: 10.1371/journal.pntd.0011639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0011639</ArticleId><ArticleId IdType="pmc">PMC10919857</ArticleId><ArticleId IdType="pubmed">38408125</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido J.M., Sevilla I.A., Beltrán-Beck B., Minguijón E., Ballesteros C., Galindo R.C., Boadella M., Lyashchenko K.P., Romero B., Geijo M.V., et al. Protection against Tuberculosis in Eurasian Wild Boar Vaccinated with Heat-Inactivated Mycobacterium Bovis. PLoS ONE. 2011;6:e24905. doi: 10.1371/journal.pone.0024905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024905</ArticleId><ArticleId IdType="pmc">PMC3173485</ArticleId><ArticleId IdType="pubmed">21935486</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas J., Risalde M.Á., Serrano M., Sevilla I., Geijo M., Ortíz J.A., Fuertes M., Ruíz-Fons J.F., de la Fuente J., Domínguez L., et al. The Response of Red Deer to Oral Administration of Heat-Inactivated Mycobacterium Bovis and Challenge with a Field Strain. Vet. Microbiol. 2017;208:195–202. doi: 10.1016/j.vetmic.2017.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2017.08.007</ArticleId><ArticleId IdType="pubmed">28888638</ArticleId></ArticleIdList></Reference><Reference><Citation>Gormley E., Ní Bhuachalla D., O’Keeffe J., Murphy D., Aldwell F.E., Fitzsimons T., Stanley P., Tratalos J.A., McGrath G., Fogarty N., et al. Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guérin (BCG) Vaccine Confers Protection against Tuberculosis. PLoS ONE. 2017;12:e0168851. doi: 10.1371/journal.pone.0168851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168851</ArticleId><ArticleId IdType="pmc">PMC5266210</ArticleId><ArticleId IdType="pubmed">28121981</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh P.D., Kurup D., Hasselschwert D.L., Wirblich C., Goetzmann J.E., Schnell M.J. The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees? Sci. Rep. 2017;7:43339. doi: 10.1038/srep43339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43339</ArticleId><ArticleId IdType="pmc">PMC5344013</ArticleId><ArticleId IdType="pubmed">28277549</ArticleId></ArticleIdList></Reference><Reference><Citation>Benn Felix J., Chaki S.P., Xu Y., Ficht T.A., Rice-Ficht A.C., Cook W.E. Protective Antibody Response Following Oral Vaccination with Microencapsulated Bacillus Anthracis Sterne Strain 34F2 Spores. NPJ Vaccines. 2020;5:59. doi: 10.1038/s41541-020-0208-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-020-0208-3</ArticleId><ArticleId IdType="pmc">PMC7351773</ArticleId><ArticleId IdType="pubmed">32685200</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., He R., Winner H., Gauduin M.-C., Zhang N., He C., Zhong G. Induction of Transmucosal Protection by Oral Vaccination with an Attenuated Chlamydia. Infect. Immun. 2023;91:e0004323. doi: 10.1128/iai.00043-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.00043-23</ArticleId><ArticleId IdType="pmc">PMC10187116</ArticleId><ArticleId IdType="pubmed">37036335</ArticleId></ArticleIdList></Reference><Reference><Citation>Tizard I.R. Chapter 18—Porcine Vaccines. In: Tizard I.R., editor. Vaccines for Veterinarians. Elsevier; Amsterdam, The Netherlands: 2021. pp. 225–242.e1.</Citation></Reference><Reference><Citation>Opriessnig T., Mattei A.A., Karuppannan A.K., Halbur P.G. Future Perspectives on Swine Viral Vaccines: Where Are We Headed? Porc. Health Manag. 2021;7:1. doi: 10.1186/s40813-020-00179-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40813-020-00179-7</ArticleId><ArticleId IdType="pmc">PMC7780603</ArticleId><ArticleId IdType="pubmed">33397477</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaziz K., Helmy Y.A., Yitbarek A., Hodgins D.C., Sharafeldin T.A., Selim M.S.H. Advances in Poultry Vaccines: Leveraging Biotechnology for Improving Vaccine Development, Stability, and Delivery. Vaccines. 2024;12:134. doi: 10.3390/vaccines12020134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12020134</ArticleId><ArticleId IdType="pmc">PMC10893217</ArticleId><ArticleId IdType="pubmed">38400118</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresch C., Lange E., Teifke J.P., Fuchs W., Klupp B., Müller T., Mettenleiter T.C., Vahlenkamp T.W. Oral Immunization of Wild Boar and Domestic Pigs with Attenuated Live Vaccine Protects against Pseudorabies Virus Infection. Vet. Microbiol. 2012;161:20–25. doi: 10.1016/j.vetmic.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2012.07.002</ArticleId><ArticleId IdType="pubmed">22832373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunu W., Jiwakanon J., Porntrakulpipat S. A Bread-Based Lyophilized C-Strain CSF Virus Vaccine as an Oral Vaccine in Pigs. Transbound. Emerg. Dis. 2019;66:1597–1601. doi: 10.1111/tbed.13185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.13185</ArticleId><ArticleId IdType="pubmed">30912869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayama Y., Sawai K., Murato Y., Yamaguchi E., Kondo S., Yamamoto T. Analysis of Effective Spatial Range of Oral Vaccination against Classical Swine Fever for Wild Boar. Prev. Vet. Med. 2023;221:106080. doi: 10.1016/j.prevetmed.2023.106080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prevetmed.2023.106080</ArticleId><ArticleId IdType="pubmed">38029645</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran M., Madhan S., Prabhu N., Geng G.Y., New R., Kwang J. Reverse Micelle-Encapsulated Recombinant Baculovirus as an Oral Vaccine against H5N1 Infection in Mice. Antiviral. Res. 2010;86:180–187. doi: 10.1016/j.antiviral.2010.02.315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.02.315</ArticleId><ArticleId IdType="pubmed">20153776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazayeri S.D., Ideris A., Zakaria Z., Shameli K., Moeini H., Omar A.R. Cytotoxicity and Immunological Responses Following Oral Vaccination of Nanoencapsulated Avian Influenza Virus H5 DNA Vaccine with Green Synthesis Silver Nanoparticles. J. Control Release. 2012;161:116–123. doi: 10.1016/j.jconrel.2012.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2012.04.015</ArticleId><ArticleId IdType="pubmed">22549012</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Z., Jiang X., Yang Z., Ren X., Gong H., Reeves M., Sheng J., Wang Y., Pan Z., Liu F., et al. Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection. PLoS ONE. 2015;10:e0129276. doi: 10.1371/journal.pone.0129276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129276</ArticleId><ArticleId IdType="pmc">PMC4471199</ArticleId><ArticleId IdType="pubmed">26083421</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H., Xie B., Gao T., Cen Q., Ren Y. Yeast Display Platform Technology to Prepare Oral Vaccine against Lethal H7N9 Virus Challenge in Mice. Microb. Cell Fact. 2020;19:53. doi: 10.1186/s12934-020-01316-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-020-01316-1</ArticleId><ArticleId IdType="pmc">PMC7053147</ArticleId><ArticleId IdType="pubmed">32122351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H., Lu X., Li S., Ren Y. High Immune Efficacy against Different Avian Influenza H5N1 Viruses Due to Oral Administration of a Saccharomyces Cerevisiae-Based Vaccine in Chickens. Sci. Rep. 2021;11:8977. doi: 10.1038/s41598-021-88413-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88413-2</ArticleId><ArticleId IdType="pmc">PMC8076243</ArticleId><ArticleId IdType="pubmed">33903693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Lu X., Yang Z., Lei H. Protective Immunity Induced by Oral Vaccination with a Recombinant Lactococcus Lactis Vaccine against H5Nx in Chickens. BMC Vet. Res. 2022;18:3. doi: 10.1186/s12917-021-03109-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-021-03109-z</ArticleId><ArticleId IdType="pmc">PMC8720943</ArticleId><ArticleId IdType="pubmed">34980121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wang Z., Xu H., Xiang B., Dang R., Yang Z. Orally Administrated Whole Yeast Vaccine Against Porcine Epidemic Diarrhea Virus Induced High Levels of IgA Response in Mice and Piglets. Viral. Immunol. 2016;29:526–531. doi: 10.1089/vim.2016.0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2016.0067</ArticleId><ArticleId IdType="pubmed">27598459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Huang L., Mou C., Zhang E., Wang Y., Cao Y., Yang Q. Mucosal Immune Responses Induced by Oral Administration Recombinant Bacillus Subtilis Expressing the COE Antigen of PEDV in Newborn Piglets. Biosci. Rep. 2019;39:BSR20182028. doi: 10.1042/BSR20191126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20191126</ArticleId><ArticleId IdType="pmc">PMC6418403</ArticleId><ArticleId IdType="pubmed">30808716</ArticleId></ArticleIdList></Reference><Reference><Citation>Do V.T., Jang J., Park J., Dao H.T., Kim K., Hahn T.-W. Recombinant Adenovirus Carrying a Core Neutralizing Epitope of Porcine Epidemic Diarrhea Virus and Heat-Labile Enterotoxin B of E. coli as a Mucosal Vaccine. Arch. Virol. 2020;165:609–618. doi: 10.1007/s00705-019-04492-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-019-04492-7</ArticleId><ArticleId IdType="pmc">PMC7087028</ArticleId><ArticleId IdType="pubmed">31950289</ArticleId></ArticleIdList></Reference><Reference><Citation>Tien N.-Q.-D., Yang M.-S., Jang Y.-S., Kwon T.-H., Reljic R., Kim M.-Y. Systemic and Oral Immunogenicity of Porcine Epidemic Diarrhea Virus Antigen Fused to Poly-Fc of Immunoglobulin G and Expressed in ΔXT/FT Nicotiana Benthamiana Plants. Front. Pharmacol. 2021;12:653064. doi: 10.3389/fphar.2021.653064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.653064</ArticleId><ArticleId IdType="pmc">PMC8120289</ArticleId><ArticleId IdType="pubmed">33995068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mebrahtu K., Teshale S., Esatu W., Habte T., Gelaye E. Evaluation of Spray and Oral Delivery of Newcastle Disease I2 Vaccine in Chicken Reared by Smallholder Farmers in Central Ethiopia. BMC Vet. Res. 2018;14:48. doi: 10.1186/s12917-018-1355-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-018-1355-x</ArticleId><ArticleId IdType="pmc">PMC5812036</ArticleId><ArticleId IdType="pubmed">29439696</ArticleId></ArticleIdList></Reference><Reference><Citation>Katalani C., Ahmadian G., Nematzadeh G., Amani J., Ehsani P., Razmyar J., Kiani G. Immunization with Oral and Parenteral Subunit Chimeric Vaccine Candidate Confers Protection against Necrotic Enteritis in Chickens. Vaccine. 2020;38:7284–7291. doi: 10.1016/j.vaccine.2020.09.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.09.047</ArticleId><ArticleId IdType="pubmed">33012608</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshirgaran M.A., Golchin M., Salehi M., Kheirandish R. Evaluation the Efficacy of Oral Immunization of Broiler Chickens with a Recombinant Lactobacillus Casei Vaccine Vector Expressing the Carboxy-Terminal Fragment of α-Toxin from Clostridium Perfringens. BMC Vet. Res. 2023;19:13. doi: 10.1186/s12917-023-03566-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-023-03566-8</ArticleId><ArticleId IdType="pmc">PMC9850811</ArticleId><ArticleId IdType="pubmed">36658534</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Jia R., Shen H., Wang M., Zhu D., Chen S., Liu M., Zhao X., Wu Y., Yang Q., et al. Oral Delivery of a DNA Vaccine Expressing the PrM and E Genes: A Promising Vaccine Strategy against Flavivirus in Ducks. Sci. Rep. 2018;8:12360. doi: 10.1038/s41598-018-30258-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30258-3</ArticleId><ArticleId IdType="pmc">PMC6098003</ArticleId><ArticleId IdType="pubmed">30120326</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Shen H., Jia R., Wang M., Chen S., Zhu D., Liu M., Zhao X., Yang Q., Wu Y., et al. Oral Vaccination with a DNA Vaccine Encoding Capsid Protein of Duck Tembusu Virus Induces Protection Immunity. Viruses. 2018;10:180. doi: 10.3390/v10040180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10040180</ArticleId><ArticleId IdType="pmc">PMC5923474</ArticleId><ArticleId IdType="pubmed">29642401</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Geng Y., Wang K., Yu Z., Yang P.O., Yang Z., He C., Huang C., Yin L., He M., et al. Adjuvant Effects of Interleukin-2 Co-Expression with VP60 in an Oral Vaccine Delivered by Attenuated Salmonella Typhimurium against Rabbit Hemorrhagic Disease. Vet. Microbiol. 2019;230:49–55. doi: 10.1016/j.vetmic.2019.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2019.01.008</ArticleId><ArticleId IdType="pubmed">30827404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai L., Ge J., Wen Z., Wang J., Wang X., Bu Z. Immune Responses in Mice and Pigs after Oral Vaccination with Rabies Virus Vectored Nipah Disease Vaccines. Vet. Microbiol. 2020;241:108549. doi: 10.1016/j.vetmic.2019.108549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2019.108549</ArticleId><ArticleId IdType="pubmed">31928698</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Qi L., Lv J., Zhang Z., Zhou P., Ma Z., Wang Y., Zhang Y., Pan L. The Immune Response to a Recombinant Lactococcus Lactis Oral Vaccine against Foot-and-Mouth Disease Virus in Mice. Biotechnol. Lett. 2020;42:1907–1917. doi: 10.1007/s10529-020-02900-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-020-02900-6</ArticleId><ArticleId IdType="pmc">PMC7210100</ArticleId><ArticleId IdType="pubmed">32385744</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewawaduge C., Senevirathne A., Lee J.H. Enhancement of Host Infectivity, Immunity, and Protective Efficacy by Addition of Sodium Bicarbonate Antacid to Oral Vaccine Formulation of Live Attenuated Salmonella Secreting Brucella Antigens. Microb. Pathog. 2020;138:103857. doi: 10.1016/j.micpath.2019.103857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2019.103857</ArticleId><ArticleId IdType="pubmed">31705999</ArticleId></ArticleIdList></Reference><Reference><Citation>Samakchan N., Thinwang P., Boonyom R. Oral Immunization of Rat with Chromosomal Expression LipL32 in Attenuated Salmonella Vaccine Induces Immune Respond against Pathogenic Leptospira. Clin. Exp. Vaccine Res. 2021;10:217–228. doi: 10.7774/cevr.2021.10.3.217.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2021.10.3.217</ArticleId><ArticleId IdType="pmc">PMC8511595</ArticleId><ArticleId IdType="pubmed">34703804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., Wang J.-Y., Pan T.-X., Jiang Y.-L., Huang H.-B., Yang W.-T., Shi C.-W., Wang J.-Z., Wang D., Zhao D.-D., et al. Oral Vaccination with Attenuated Salmonella Encoding the Trichinella Spiralis 43-kDa Protein Elicits Protective Immunity in BALB/c Mice. Acta Trop. 2021;222:106071. doi: 10.1016/j.actatropica.2021.106071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actatropica.2021.106071</ArticleId><ArticleId IdType="pubmed">34331898</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechler-Dreibi M.L., Almeida H.M.S., Sonalio K., Martines M.A.C., Petri F.A.M., Zambotti B.B., Ferreira M.M., Storino G.Y., Martins T.S., Montassier H.J., et al. Oral Vaccination of Piglets against Mycoplasma Hyopneumoniae Using Silica SBA-15 as an Adjuvant Effectively Reduced Consolidation Lung Lesions at Slaughter. Sci. Rep. 2021;11:22377. doi: 10.1038/s41598-021-01883-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01883-2</ArticleId><ArticleId IdType="pmc">PMC8599662</ArticleId><ArticleId IdType="pubmed">34789792</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucero M.S., Chimeno Zoth S., Jaton J., Gravisaco M.J., Pinto S., Richetta M., Berinstein A., Gómez E. Oral Immunization With Plant-Based Vaccine Induces a Protective Response Against Infectious Bursal Disease. Front. Plant Sci. 2021;12:741469. doi: 10.3389/fpls.2021.741469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2021.741469</ArticleId><ArticleId IdType="pmc">PMC8636702</ArticleId><ArticleId IdType="pubmed">34868126</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Hua D., Qu Q., Cao H., Feng Z., Liu N., Huang J., Zhang L. Oral Immunization with Recombinant Saccharomyces Cerevisiae Expressing Viral Capsid Protein 2 of Infectious Bursal Disease Virus Induces Unique Specific Antibodies and Protective Immunity. Vaccines. 2023;11:1849. doi: 10.3390/vaccines11121849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11121849</ArticleId><ArticleId IdType="pmc">PMC10747824</ArticleId><ArticleId IdType="pubmed">38140252</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Luo P., Chen Y., Xu J., Sun J., Guan C., Wang P., Chen M., Zhang X., Zhu Y., et al. Regulated Delayed Attenuation Improves Vaccine Efficacy in Preventing Infection from Avian Pathogenic E. coli O78 and Salmonella Typhimurium. Vet. Microbiol. 2021;254:109012. doi: 10.1016/j.vetmic.2021.109012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2021.109012</ArticleId><ArticleId IdType="pubmed">33611126</ArticleId></ArticleIdList></Reference><Reference><Citation>Shringi S., Sheng H., Potter A.A., Minnich S.A., Hovde C.J., Besser T.E. Repeated Oral Vaccination of Cattle with Shiga Toxin-Negative E. coli O157:H7 Reduces Carriage of Wild-Type E. coli O157:H7 after Challenge. Appl. Environ. Microbiol. 2021;87:e02183-20. doi: 10.1128/AEM.02183-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02183-20</ArticleId><ArticleId IdType="pmc">PMC7783330</ArticleId><ArticleId IdType="pubmed">33158889</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Weken H., Jahantigh H.R., Cox E., Devriendt B. Targeted Delivery of Oral Vaccine Antigens to Aminopeptidase N Protects Pigs against Pathogenic E. coli Challenge Infection. Front. Immunol. 2023;14:1192715. doi: 10.3389/fimmu.2023.1192715.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1192715</ArticleId><ArticleId IdType="pmc">PMC10338862</ArticleId><ArticleId IdType="pubmed">37457692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi Y., Lin S.M., Jang A.-Y., Ahn K.B., Ji H.J., Guo H.-C., Lim S., Seo H.S. Effective Mucosal Live Attenuated Salmonella Vaccine by Deleting Phosphotransferase System Component Genes ptsI and Crr. J. Microbiol. 2019;57:64–73. doi: 10.1007/s12275-019-8416-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12275-019-8416-0</ArticleId><ArticleId IdType="pubmed">30552632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar H., Rahman S.U., Ali S., Javed M.T. Evaluation of a Salmonella Strain Isolated from Honeybee Gut as a Potential Live Oral Vaccine Against Lethal Infection of Salmonella Typhimurium. Pol. J. Microbiol. 2019;68:173–183. doi: 10.33073/pjm-2019-017.</Citation><ArticleIdList><ArticleId IdType="doi">10.33073/pjm-2019-017</ArticleId><ArticleId IdType="pmc">PMC7260634</ArticleId><ArticleId IdType="pubmed">31257790</ArticleId></ArticleIdList></Reference><Reference><Citation>Renu S., Han Y., Dhakal S., Lakshmanappa Y.S., Ghimire S., Feliciano-Ruiz N., Senapati S., Narasimhan B., Selvaraj R., Renukaradhya G.J. Chitosan-Adjuvanted Salmonella Subunit Nanoparticle Vaccine for Poultry Delivered through Drinking Water and Feed. Carbohydr. Polym. 2020;243:116434. doi: 10.1016/j.carbpol.2020.116434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2020.116434</ArticleId><ArticleId IdType="pubmed">32532387</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginson E.E., Panda A., Toapanta F.R., Terzi M.C., Jones J.A., Sen S., Permala-Booth J., Pasetti M.F., Sztein M.B., DeTolla L., et al. Immunogenicity and Efficacy of Live-Attenuated Salmonella Typhimurium Vaccine Candidate CVD 1926 in a Rhesus Macaque Model of Gastroenteritis. Infect. Immun. 2021;89:e0008721. doi: 10.1128/IAI.00087-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00087-21</ArticleId><ArticleId IdType="pmc">PMC8445168</ArticleId><ArticleId IdType="pubmed">34310885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa-Repáraz J., Sebastià E., Sitjà M., Tamayo I., Irache J.M., Gamazo C. Protection Conferred by Drinking Water Administration of a Nanoparticle-Based Vaccine against Salmonella Enteritidis in Hens. Vaccines. 2021;9:216. doi: 10.3390/vaccines9030216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030216</ArticleId><ArticleId IdType="pmc">PMC8001700</ArticleId><ArticleId IdType="pubmed">33802556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai P., Wu H.-C., Ding H.-C., Li S.-J., Bao E.-D., Yang B.-S., Li Y.-J., Gao X.-L., Duan Q., Zhu G.-Q. Safety and Protective Effects of an Avirulent Salmonella Gallinarum Isolate as a Vaccine Candidate against Salmonella Gallinarum Infections in Young Chickens. Vet. Immunol. Immunopathol. 2022;253:110501. doi: 10.1016/j.vetimm.2022.110501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2022.110501</ArticleId><ArticleId IdType="pubmed">36332427</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H., La T.-M., Lee H.-J., Kim T., Song S.-U., Park E., Park G.-H., Choi I.-S., Park S.-Y., Lee J.-B., et al. Evaluation of Immune Responses and Protective Efficacy of a Novel Live Attenuated Salmonella Enteritidis Vaccine Candidate in Chickens. Vaccines. 2022;10:1405. doi: 10.3390/vaccines10091405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10091405</ArticleId><ArticleId IdType="pmc">PMC9501076</ArticleId><ArticleId IdType="pubmed">36146484</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y., Zhang H., Pan N., Liu Y., Sheng S., Li H., Bao X., Wang X. Oral Administration with Recombinant Attenuated Regulated Delayed Lysis Salmonella Vaccines Protecting against Staphylococcus Aureus Kidney Abscess Formation. Vaccines. 2022;10:1073. doi: 10.3390/vaccines10071073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071073</ArticleId><ArticleId IdType="pmc">PMC9324569</ArticleId><ArticleId IdType="pubmed">35891237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaldis A., Uddin M.S., Guluarte J.O., Martin C., Alexander T.W., Menassa R. Development of a Plant-Based Oral Vaccine Candidate against the Bovine Respiratory Pathogen Mannheimia Haemolytica. Front. Plant Sci. 2023;14:1251046. doi: 10.3389/fpls.2023.1251046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2023.1251046</ArticleId><ArticleId IdType="pmc">PMC10542578</ArticleId><ArticleId IdType="pubmed">37790785</ArticleId></ArticleIdList></Reference><Reference><Citation>Soutter F., Werling D., Nolan M., Küster T., Attree E., Marugán-Hernández V., Kim S., Tomley F.M., Blake D.P. A Novel Whole Yeast-Based Subunit Oral Vaccine Against Eimeria Tenella in Chickens. Front. Immunol. 2022;13:809711. doi: 10.3389/fimmu.2022.809711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.809711</ArticleId><ArticleId IdType="pmc">PMC8848252</ArticleId><ArticleId IdType="pubmed">35185896</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Qu H., Zheng W., Zhang Y., Li Y., Pan T., Li J., Yang W., Cao X., Jiang Y., et al. Oral Vaccination with a Recombinant Lactobacillus plantarum Expressing the Eimeria Tenella Rhoptry Neck 2 Protein Elicits Protective Immunity in Broiler Chickens Infected with Eimeria Tenella. Parasit. Vectors. 2024;17:277. doi: 10.1186/s13071-024-06355-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13071-024-06355-w</ArticleId><ArticleId IdType="pmc">PMC11212160</ArticleId><ArticleId IdType="pubmed">38943202</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.-Y., Chang W.-C., Wu M.-C., Liaw J., Shiau A.-L., Chu C.-Y. Oral DNA Vaccine Adjuvanted with Cyclic Peptide Nanotubes Induced a Virus-Specific Antibody Response in Ducklings against Goose Parvovirus. Vet. Q. 2023;43:1–9. doi: 10.1080/01652176.2023.2205480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01652176.2023.2205480</ArticleId><ArticleId IdType="pmc">PMC10150611</ArticleId><ArticleId IdType="pubmed">37074390</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshraghisamani R., Facciuolo A., Harman-McKenna V., Illanes O., De Buck J. Immunogenicity and Efficacy of an Oral Live-Attenuated Vaccine for Bovine Johne’s Disease. Front. Immunol. 2023;14:1307621. doi: 10.3389/fimmu.2023.1307621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1307621</ArticleId><ArticleId IdType="pmc">PMC10810994</ArticleId><ArticleId IdType="pubmed">38283338</ArticleId></ArticleIdList></Reference><Reference><Citation>Brudeseth B.E., Wiulsrød R., Fredriksen B.N., Lindmo K., Løkling K.-E., Bordevik M., Steine N., Klevan A., Gravningen K. Status and Future Perspectives of Vaccines for Industrialised Fin-Fish Farming. Fish Shellfish Immunol. 2013;35:1759–1768. doi: 10.1016/j.fsi.2013.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2013.05.029</ArticleId><ArticleId IdType="pubmed">23769873</ArticleId></ArticleIdList></Reference><Reference><Citation>Embregts C.W.E., Forlenza M. Oral Vaccination of Fish: Lessons from Humans and Veterinary Species. Dev. Comp. Immunol. 2016;64:118–137. doi: 10.1016/j.dci.2016.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dci.2016.03.024</ArticleId><ArticleId IdType="pubmed">27018298</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar A.K., Manna S.K., Thomas Allnutt F.C. Viral Vaccines for Farmed Finfish. Virusdisease. 2014;25:1–17. doi: 10.1007/s13337-013-0186-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-013-0186-4</ArticleId><ArticleId IdType="pmc">PMC3889245</ArticleId><ArticleId IdType="pubmed">24426306</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerset I., Krossøy B., Biering E., Frost P. Vaccines for Fish in Aquaculture. Expert Rev. Vaccines. 2005;4:89–101. doi: 10.1586/14760584.4.1.89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.4.1.89</ArticleId><ArticleId IdType="pubmed">15757476</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Hu X., Miao L., Chen J. Current Status and Development Prospects of Aquatic Vaccines. Front. Immunol. 2022;13:1040336. doi: 10.3389/fimmu.2022.1040336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1040336</ArticleId><ArticleId IdType="pmc">PMC9684733</ArticleId><ArticleId IdType="pubmed">36439092</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoloki S., Munang’andu H.M., Evensen Ø. Oral Vaccination of Fish—Antigen Preparations, Uptake, and Immune Induction. Front. Immunol. 2015;6:519. doi: 10.3389/fimmu.2015.00519.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00519</ArticleId><ArticleId IdType="pmc">PMC4610203</ArticleId><ArticleId IdType="pubmed">26539192</ArticleId></ArticleIdList></Reference><Reference><Citation>Anuradha K., Foo H.L., Mariana N.S., Loh T.C., Yusoff K., Hassan M.D., Sasan H., Raha A.R. Live Recombinant Lactococcus Lactis Vaccine Expressing Aerolysin Genes D1 and D4 for Protection against Aeromonas Hydrophila in Tilapia (Oreochromis niloticus) J. Appl. Microbiol. 2010;109:1632–1642. doi: 10.1111/j.1365-2672.2010.04789.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2672.2010.04789.x</ArticleId><ArticleId IdType="pubmed">20602654</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L.P., Wang R., Liang W.W., Huang T., Huang Y., Luo F.G., Lei A.Y., Chen M., Gan X. Development of Live Attenuated Streptococcus Agalactiae Vaccine for Tilapia via Continuous Passage in Vitro. Fish Shellfish Immunol. 2015;45:955–963. doi: 10.1016/j.fsi.2015.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2015.06.014</ArticleId><ArticleId IdType="pubmed">26087276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong K.Y., Megat Mazhar Khair M.H., Song A.A.L., Masarudin M.J., Loh J.Y., Chong C.M., Beardall J., Teo M.Y.M., In L.L.A. Recombinant Lactococcal-Based Oral Vaccine for Protection against Streptococcus Agalactiae Infections in Tilapia (Oreochromis niloticus) Fish Shellfish Immunol. 2024;149:109572. doi: 10.1016/j.fsi.2024.109572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2024.109572</ArticleId><ArticleId IdType="pubmed">38636739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise D.J., Greenway T.E., Byars T.S., Griffin M.J., Khoo L.H. Oral Vaccination of Channel Catfish against Enteric Septicemia of Catfish Using a Live Attenuated Edwardsiella Ictaluri Isolate. J. Aquat. Anim. Health. 2015;27:135–143. doi: 10.1080/08997659.2015.1032440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08997659.2015.1032440</ArticleId><ArticleId IdType="pubmed">26030354</ArticleId></ArticleIdList></Reference><Reference><Citation>Nho S.W., Abdelhamed H., Karsi A., Lawrence M.L. Improving Safety of a Live Attenuated Edwardsiella Ictaluri Vaccine against Enteric Septicemia of Catfish and Evaluation of Efficacy. Vet. Microbiol. 2017;210:83–90. doi: 10.1016/j.vetmic.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2017.09.004</ArticleId><ArticleId IdType="pubmed">29103702</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan K., Hua X., Wang Y., Wang Y., Chen Y., Shi W., Tang L., Li Y., Liu M. Oral Immunization with a Recombinant Lactobacillus Expressing CK6 Fused with VP2 Protein against IPNV in Rainbow Trout (Oncorhynchus mykiss) Fish Shellfish Immunol. 2018;83:223–231. doi: 10.1016/j.fsi.2018.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2018.09.034</ArticleId><ArticleId IdType="pubmed">30217507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Hua X., Ren X., Duan K., Gao S., Sun J., Feng Y., Zhou Y., Guan X., Li D., et al. Oral Immunization with Recombinant Lactobacillus Casei Displayed AHA1-CK6 and VP2 Induces Protection against Infectious Pancreatic Necrosis in Rainbow Trout (Oncorhynchus mykiss) Fish Shellfish Immunol. 2020;100:18–26. doi: 10.1016/j.fsi.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2020.03.001</ArticleId><ArticleId IdType="pubmed">32142871</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo J.Y., Chung H.J., Kim T.J. Codon-Optimized Expression of Fish Iridovirus Capsid Protein in Yeast and Its Application as an Oral Vaccine Candidate. J. Fish Dis. 2013;36:763–768. doi: 10.1111/jfd.12037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfd.12037</ArticleId><ArticleId IdType="pubmed">23488597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y.J., Kwon T.H., Seo J.Y., Kim T.J. Oral Immunization of Fish against Iridovirus Infection Using Recombinant Antigen Produced from Rice Callus. Vaccine. 2013;31:5210–5215. doi: 10.1016/j.vaccine.2013.08.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.08.085</ArticleId><ArticleId IdType="pubmed">24021312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi G.R., Hwang J.Y., Kwon M.-G., Kim H.J., Kang H.A., Kim H.-J. Protective Immunity against Nervous Necrosis Virus in Convict Grouper Epinephelus Septemfasciatus Following Vaccination with Virus-like Particles Produced in Yeast Saccharomyces Cerevisiae. Vet. Microbiol. 2015;177:214–218. doi: 10.1016/j.vetmic.2015.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2015.02.021</ArticleId><ArticleId IdType="pubmed">25759291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballesteros N.A., Rodriguez Saint-Jean S., Perez-Prieto S.I. Immune Responses to Oral pcDNA-VP2 Vaccine in Relation to Infectious Pancreatic Necrosis Virus Carrier State in Rainbow Trout Oncorhynchus mykiss. Vet. Immunol. Immunopathol. 2015;165:127–137. doi: 10.1016/j.vetimm.2015.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2015.04.001</ArticleId><ArticleId IdType="pubmed">25892368</ArticleId></ArticleIdList></Reference><Reference><Citation>Adomako M., St-Hilaire S., Zheng Y., Eley J., Marcum R.D., Sealey W., Donahower B.C., Lapatra S., Sheridan P.P. Oral DNA Vaccination of Rainbow Trout, Oncorhynchus mykiss (Walbaum), against Infectious Haematopoietic Necrosis Virus Using PLGA [Poly(D,L-Lactic-Co-Glycolic Acid)] Nanoparticles. J. Fish Dis. 2012;35:203–214. doi: 10.1111/j.1365-2761.2011.01338.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2761.2011.01338.x</ArticleId><ArticleId IdType="pubmed">22324344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballesteros N.A., Alonso M., Saint-Jean S.R., Perez-Prieto S.I. An Oral DNA Vaccine against Infectious Haematopoietic Necrosis Virus (IHNV) Encapsulated in Alginate Microspheres Induces Dose-Dependent Immune Responses and Significant Protection in Rainbow Trout (Oncorrhynchus Mykiss) Fish Shellfish Immunol. 2015;45:877–888. doi: 10.1016/j.fsi.2015.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2015.05.045</ArticleId><ArticleId IdType="pubmed">26054788</ArticleId></ArticleIdList></Reference><Reference><Citation>Smreczak M., Orłowska A., Müller T., Freuling C.M., Kawiak-Sadurska M., Trębas P. Vaccine-Induced Rabies in a Red Fox in Poland. J. Vet. Res. 2022;66:473–477. doi: 10.2478/jvetres-2022-0065.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/jvetres-2022-0065</ArticleId><ArticleId IdType="pmc">PMC9944997</ArticleId><ArticleId IdType="pubmed">36846029</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.J.Y., Loh J.M.S., Fujihashi K., Kiyono H. Mucosal Vaccination: Onward and Upward. Expert Rev. Vaccines. 2023;22:885–899. doi: 10.1080/14760584.2023.2268724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2023.2268724</ArticleId><ArticleId IdType="pubmed">37817433</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>